Carol A Kauffman

Summary

Affiliation: University of Michigan
Country: USA

Publications

  1. ncbi request reprint Management of histoplasmosis
    Carol A Kauffman
    University of Michigan Medical School, Infectious Diseases Division, Veterans Affairs Healthcare System, Ann Arbor, Michigan, USA
    Expert Opin Pharmacother 3:1067-72. 2002
  2. doi request reprint Diagnosis and management of fungal urinary tract infection
    Carol A Kauffman
    Division of Infectious Diseases, Veterans Affairs Ann Arbor Healthcare System, University of Michigan Medical School, 2215 Fuller Road, Ann Arbor, MI 48105, USA Electronic address
    Infect Dis Clin North Am 28:61-74. 2014
  3. doi request reprint Update on echinocandin antifungals
    Carol A Kauffman
    Division of Infectious Diseases, Department of Internal Medicine, Veterans Affairs Ann Arbor Healthcare System, University of Michigan Medical School, Ann Arbor, Michigan 48105, USA
    Semin Respir Crit Care Med 29:211-9. 2008
  4. ncbi request reprint Therapeutic and preventative options for the management of vancomycin-resistant enterococcal infections
    Carol A Kauffman
    Division of Infectious Diseases, University of Michigan Medical School, Ann Arbor Veterans Affairs Healthcare System, 2215 Fuller Road, Ann Arbor, MI 48105, USA
    J Antimicrob Chemother 51:iii23-30. 2003
  5. ncbi request reprint Clinical practice guidelines for the management of sporotrichosis: 2007 update by the Infectious Diseases Society of America
    Carol A Kauffman
    Infectious Diseases Section, Veterans Affairs Medical Center, University of Michigan Medical School, Ann Arbor, MI 48105, USA
    Clin Infect Dis 45:1255-65. 2007
  6. doi request reprint Histoplasmosis
    Carol A Kauffman
    Division of Infectious Diseases, Veterans Affairs Ann Arbor Healthcare System, Department of Internal Medicine, University of Michigan Medical School, Ann Arbor, MI 48105, USA
    Clin Chest Med 30:217-25, v. 2009
  7. ncbi request reprint Candiduria
    Carol A Kauffman
    Division of Infectious Diseases, University of Michigan Medical School, Veterans Affairs Ann Arbor Healthcare System, Ann Arbor, MI, USA
    Clin Infect Dis 41:S371-6. 2005
  8. ncbi request reprint Fungal infections
    Carol A Kauffman
    University of Michigan Medical School and Infectious Diseases Section, Veterans Affairs Ann Arbor Healthcare System, Ann Arbor, Michigan 48105, USA
    Proc Am Thorac Soc 3:35-40. 2006
  9. doi request reprint Diagnosis of histoplasmosis in immunosuppressed patients
    Carol A Kauffman
    Division of Infectious Diseases, University of Michigan Medical School, Veterans Affairs Ann Arbor Healthcare System, Ann Arbor, Michigan 48105, USA
    Curr Opin Infect Dis 21:421-5. 2008
  10. ncbi request reprint Clinical efficacy of new antifungal agents
    Carol A Kauffman
    Division of Infectious Diseases, Department of Internal Medicine, University of Michigan Medical School, Veterans Affairs Ann Arbor Healthcare System, Ann Arbor, MI 48105, USA
    Curr Opin Microbiol 9:483-8. 2006

Detail Information

Publications75

  1. ncbi request reprint Management of histoplasmosis
    Carol A Kauffman
    University of Michigan Medical School, Infectious Diseases Division, Veterans Affairs Healthcare System, Ann Arbor, Michigan, USA
    Expert Opin Pharmacother 3:1067-72. 2002
    ..Most patients who require initial treatment with amphotericin B respond quickly and can then be switched to itraconazole to finish the course of therapy...
  2. doi request reprint Diagnosis and management of fungal urinary tract infection
    Carol A Kauffman
    Division of Infectious Diseases, Veterans Affairs Ann Arbor Healthcare System, University of Michigan Medical School, 2215 Fuller Road, Ann Arbor, MI 48105, USA Electronic address
    Infect Dis Clin North Am 28:61-74. 2014
    ..This overview focuses only on candiduria and Candida urinary tract infection because they are common and many times present perplexing management issues. ..
  3. doi request reprint Update on echinocandin antifungals
    Carol A Kauffman
    Division of Infectious Diseases, Department of Internal Medicine, Veterans Affairs Ann Arbor Healthcare System, University of Michigan Medical School, Ann Arbor, Michigan 48105, USA
    Semin Respir Crit Care Med 29:211-9. 2008
    ..Hospital formulary committees are likely to view the three echinocandins as equivalent agents and place the least expensive agent on formulary...
  4. ncbi request reprint Therapeutic and preventative options for the management of vancomycin-resistant enterococcal infections
    Carol A Kauffman
    Division of Infectious Diseases, University of Michigan Medical School, Ann Arbor Veterans Affairs Healthcare System, 2215 Fuller Road, Ann Arbor, MI 48105, USA
    J Antimicrob Chemother 51:iii23-30. 2003
    ..These features and current clinical evidence suggest that ramoplanin may have a role in future gastrointestinal decolonization regimens...
  5. ncbi request reprint Clinical practice guidelines for the management of sporotrichosis: 2007 update by the Infectious Diseases Society of America
    Carol A Kauffman
    Infectious Diseases Section, Veterans Affairs Medical Center, University of Michigan Medical School, Ann Arbor, MI 48105, USA
    Clin Infect Dis 45:1255-65. 2007
    ..Recommendations are also provided for the treatment of sporotrichosis in pregnant women and in children...
  6. doi request reprint Histoplasmosis
    Carol A Kauffman
    Division of Infectious Diseases, Veterans Affairs Ann Arbor Healthcare System, Department of Internal Medicine, University of Michigan Medical School, Ann Arbor, MI 48105, USA
    Clin Chest Med 30:217-25, v. 2009
    ..Treatment guidelines have been updated recently and are reviewed for the various forms of histoplasmosis...
  7. ncbi request reprint Candiduria
    Carol A Kauffman
    Division of Infectious Diseases, University of Michigan Medical School, Veterans Affairs Ann Arbor Healthcare System, Ann Arbor, MI, USA
    Clin Infect Dis 41:S371-6. 2005
    ..Until reliable methods to distinguish infection from colonization are developed, further treatment trials are unlikely to provide information to guide the clinician in the treatment of candiduria...
  8. ncbi request reprint Fungal infections
    Carol A Kauffman
    University of Michigan Medical School and Infectious Diseases Section, Veterans Affairs Ann Arbor Healthcare System, Ann Arbor, Michigan 48105, USA
    Proc Am Thorac Soc 3:35-40. 2006
    ..Treatment with amphotericin B, long the mainstay of antifungal therapy despite its inherent toxicity, is required much less often since the introduction of these new antifungal agents...
  9. doi request reprint Diagnosis of histoplasmosis in immunosuppressed patients
    Carol A Kauffman
    Division of Infectious Diseases, University of Michigan Medical School, Veterans Affairs Ann Arbor Healthcare System, Ann Arbor, Michigan 48105, USA
    Curr Opin Infect Dis 21:421-5. 2008
    ..To define the most appropriate studies for making a diagnosis of histoplasmosis in immunosuppressed patients...
  10. ncbi request reprint Clinical efficacy of new antifungal agents
    Carol A Kauffman
    Division of Infectious Diseases, Department of Internal Medicine, University of Michigan Medical School, Veterans Affairs Ann Arbor Healthcare System, Ann Arbor, MI 48105, USA
    Curr Opin Microbiol 9:483-8. 2006
    ..These agents have also been shown to be effective in the treatment of non-Aspergillus mould infections, several of the endemic mycoses and serious Candida infections...
  11. ncbi request reprint Endemic mycoses: blastomycosis, histoplasmosis, and sporotrichosis
    Carol A Kauffman
    University of Michigan Medical School, Ann Arbor, MI 48109, USA
    Infect Dis Clin North Am 20:645-62, vii. 2006
    ..This article discusses histoplasmosis and blastomycosis. Sporotrichosis, which differs in that it is usually a localized lymphocutaneous infection, is included because it shares the characteristics of endemic mycoses...
  12. pmc Histoplasmosis: a clinical and laboratory update
    Carol A Kauffman
    Infectious Diseases Division, Department of Internal Medicine, Ann Arbor Veterans Affairs Healthcare System, University of Michigan Medical School, Ann Arbor, MI, USA
    Clin Microbiol Rev 20:115-32. 2007
    ..Itraconazole is the azole of choice following initial amphotericin B treatment and for primary treatment of mild to moderate histoplasmosis...
  13. ncbi request reprint Endemic mycoses in patients with hematologic malignancies
    Carol A Kauffman
    Division of Infectious Diseases, Ann Arbor Veterans Affairs Healthcare System, University of Michigan Medical School, 48105, USA
    Semin Respir Infect 17:106-12. 2002
    ..Azole antifungal agents can be used in those patients who respond quickly to amphotericin B and for those requiring long-term suppressive therapy...
  14. ncbi request reprint Antifungal agents in the 1990s. Current status and future developments
    C A Kauffman
    Department of Internal Medicine, University of Michigan Medical School, Ann Arbor, USA
    Drugs 53:539-49. 1997
    ..With the increasing number of available antifungal drugs, future studies will help define the appropriate niche for each and the possible benefit of therapy with combinations of drugs...
  15. ncbi request reprint Endogenous Aspergillus endophthalmitis: report of 3 cases and review of the literature
    James Riddell Iv
    Division of Infectious Diseases, Department of Internal Medicine, Veterans Affairs Ann Arbor Healthcare System and University of Michigan Medical School, Ann Arbor, Michigan 48105, USA
    Medicine (Baltimore) 81:311-20. 2002
  16. ncbi request reprint Practice guidelines for the management of patients with sporotrichosis. For the Mycoses Study Group. Infectious Diseases Society of America
    C A Kauffman
    Division of Infectious Diseases, University of Michigan Medical School and Veterans Affairs Medical Center, Ann Arbor 48105, USA
    Clin Infect Dis 30:684-7. 2000
    ..AIDS patients most often have disseminated infection and require life-long suppressive therapy with itraconazole after initial use of amphotericin B...
  17. ncbi request reprint Prospective multicenter surveillance study of funguria in hospitalized patients. The National Institute for Allergy and Infectious Diseases (NIAID) Mycoses Study Group
    C A Kauffman
    University of Michigan and Veterans Affairs Medical Center, Ann Arbor, MI 48105, USA
    Clin Infect Dis 30:14-8. 2000
    ..5%, and with amphotericin B bladder irrigation it was 54.4%. Only 7 patients (1.3%) had documented candidemia. The mortality rate was 19.8%, reflecting the multiple serious underlying illnesses found in these patients with funguria...
  18. ncbi request reprint Colorimetric method for susceptibility testing of voriconazole and other triazoles against Candida species
    C A Kauffman
    Department of Internal Medicine, Ann Arbor Veterans Affairs Health System, University of Michigan Medical 48105, USA
    Mycoses 42:539-42. 1999
    ..2%) discordant readings (> or = 3 dilutions different) were noted in C. glabrata isolates, and all but two isolates showing discordance had higher minimum inhibitory concentration readings with the colorimetric method...
  19. ncbi request reprint Systemic antifungal agents. What is in the pipeline?
    C A Kauffman
    Department of Internal Medicine, Veterans Affairs Health System, University of Michigan Medical School, Ann Arbor, USA
    Drugs R D 1:153-9. 1999
    ..New agents that target the fungal cell wall, a structure with no homology in mammalian cells, may prove to be less toxic and are currently of great interest...
  20. ncbi request reprint Fungal infections in older adults
    C A Kauffman
    Division of Infectious Diseases, Department of Internal Medicine, Ann Arbor Veterans Affairs Healthcare System, 2215 Fuller Road, Ann Arbor, MI 48105, USA
    Clin Infect Dis 33:550-5. 2001
    ..Although they are less toxic, azoles must be used carefully for treatment of older adults, who are more likely to experience serious drug-drug interactions than are younger persons...
  21. ncbi request reprint Treatment of systemic fungal infections in older patients: achieving optimal outcomes
    C A Kauffman
    Infectious Diseases Section, Veterans Affairs Ann Arbor Healthcare System, University of Michigan Medical School, 48105, USA
    Drugs Aging 18:313-23. 2001
    ..Newer lipid formulations of amphotericin B can obviate some of these toxicities, but their role in the treatment of systemic fungal infections in older adults has not yet been clarified...
  22. doi request reprint Candida urinary tract infections--diagnosis
    Carol A Kauffman
    Division of Infectious Diseases, Department of Internal Medicine, University of Michigan, Veterans Affairs Ann Arbor Healthcare System, Ann Arbor, Michigan, USA
    Clin Infect Dis 52:S452-6. 2011
    ....
  23. doi request reprint Preventing hospital-acquired urinary tract infection in the United States: a national study
    Sanjay Saint
    Veterans Affairs Ann Arbor Healthcare System, Ann Arbor, Michigan, USA
    Clin Infect Dis 46:243-50. 2008
    ..We conducted a national study to examine the current practices used by hospitals to prevent hospital-acquired UTI...
  24. pmc Factors associated with mortality in transplant patients with invasive aspergillosis
    John W Baddley
    Department of Medicine, Division of Infectious Diseases, University of Alabama at Birmingham, AL 35294 0006, USA
    Clin Infect Dis 50:1559-67. 2010
    ..The purpose of this study was to evaluate factors associated with mortality in transplant patients with IA...
  25. pmc Indwelling device use and antibiotic resistance in nursing homes: identifying a high-risk group
    Lona Mody
    Division of Geriatric Medicine, University of Michigan Medical School, Ann Arbor, Michigan, USA
    J Am Geriatr Soc 55:1921-6. 2007
    ..To quantify the relationship between indwelling devices (urinary catheters, feeding tubes, and peripherally inserted central catheters) and carriage of antimicrobial-resistant pathogens in nursing home residents...
  26. pmc Conceptual model for reducing infections and antimicrobial resistance in skilled nursing facilities: focusing on residents with indwelling devices
    Lona Mody
    Division of Geriatric Medicine, Veterans Affairs Ann Arbor Health Service Research and Development Center of Excellence, Ann Arbor, MI 48105, USA
    Clin Infect Dis 52:654-61. 2011
    ..If this strategy is effective, similar strategies can be studied and implemented for other high-risk groups...
  27. doi request reprint Blastomycosis
    Jeannina A Smith
    Division of Infectious Diseases, University of Michigan Medical School, Veterans Affairs Ann Arbor Healthcare System, 2215 Fuller Road, Ann Arbor, MI 48105, USA
    Proc Am Thorac Soc 7:173-80. 2010
    ..Updated guidelines from the Infectious Diseases Society of America are available to aid clinicians in the management of the various forms of blastomycosis...
  28. ncbi request reprint Vancomycin-resistant enterococcal colonization and infection in liver transplant candidates and recipients: a prospective surveillance study
    Shelly A McNeil
    Division of Infectious Diseases, Department of Internal Medicine, University of Michigan Health System, Ann Arbor, Michigan, USA
    Clin Infect Dis 42:195-203. 2006
    ..We performed a prospective study among patients awaiting transplantation to assess rates, risk factors, and outcomes associated with VRE colonization before and after transplantation...
  29. pmc Epidemiology of Staphylococcus aureus colonization in nursing home residents
    Lona Mody
    Division of Geriatric Medicine, Veteran Affairs Ann Arbor Healthcare System, University of Michigan Medical School, Ann Arbor 48105, USA
    Clin Infect Dis 46:1368-73. 2008
    ..aureus (MRSA) has emerged in community nursing homes...
  30. doi request reprint Candida urinary tract infections--epidemiology
    Jack D Sobel
    Division of Infectious Diseases, Wayne State University School of Medicine, Detroit, Michigan, USA
    Clin Infect Dis 52:S433-6. 2011
    ..In ICU patients, although candiduria is a marker for increased mortality, it is only rarely attributable to Candida urinary tract infection...
  31. ncbi request reprint Changing epidemiology of rare mould infections: implications for therapy
    Anurag N Malani
    Division of Infectious Diseases, University of Michigan Health System, Veterans Affairs Ann Arbor Healthcare System, Ann Arbor, Michigan, USA
    Drugs 67:1803-12. 2007
    ..It is not known whether posaconazole is effective as primary therapy for zygomycosis; the use of this agent for that purpose awaits clinical trials with the recently developed intravenous formulation of posaconazole...
  32. ncbi request reprint Voriconazole: a new triazole antifungal agent
    Leonard B Johnson
    Division of Infectious Diseases, St John Hospital and Medical Center, Wayne State University, Detroit, MI 48236, USA
    Clin Infect Dis 36:630-7. 2003
    ....
  33. pmc Patterns of susceptibility of Aspergillus isolates recovered from patients enrolled in the Transplant-Associated Infection Surveillance Network
    John W Baddley
    Department of Medicine, Division of Infectious Diseases, University of Alabama at Birmingham, Birmingham, AL 35294 0006, USA
    J Clin Microbiol 47:3271-5. 2009
    ..61; P = 0.065). Significant relationships of in vitro MIC to all-cause mortality at 6 and 12 weeks for VOR or AMB were not found...
  34. doi request reprint Recognition and prevention of nosocomial invasive fungal infections in the intensive care unit
    Jeannina A Smith
    Division of Infectious Diseases, University of Michigan Medical School, Veterans Affairs Ann Arbor Healthcare System, Ann Arbor, MI, USA
    Crit Care Med 38:S380-7. 2010
    ..However, the most immediate benefit has been realized with the introduction of new antifungal agents that have proved to be safer than those available in the past...
  35. doi request reprint Endemic fungal infections in patients receiving tumour necrosis factor-alpha inhibitor therapy
    Jeannina A Smith
    Division of Infectious Diseases, University of Michigan Medical School, Veterans Affairs Ann Arbor Healthcare System, Ann Arbor, Michigan, USA
    Drugs 69:1403-15. 2009
    ....
  36. ncbi request reprint Practice guidelines for the management of patients with blastomycosis. Infectious Diseases Society of America
    S W Chapman
    Division of Infectious Diseases, University of Mississippi Medical Center, Jackson, MS 39216 4505, USA
    Clin Infect Dis 30:679-83. 2000
    ..Although there are no comparative trials, itraconazole appears more efficacious than either ketoconazole or fluconazole. Thus, itraconazole is the initial treatment of choice for nonlife-threatening non-CNS blastomycosis...
  37. doi request reprint Bartonella henselae infections in solid organ transplant recipients: report of 5 cases and review of the literature
    Georgios Psarros
    Division of Infectious Diseases, Department of Internal Medicine, University of Michigan Health System, Veterans Affairs Ann Arbor Healthcare System, Ann Arbor, Michigan, USA
    Medicine (Baltimore) 91:111-21. 2012
    ..henselae infection. Identifying B. henselae as the causative organism often requires multiple diagnostic studies. Once the diagnosis is established, most solid organ transplant recipients respond appropriately to antimicrobial treatment...
  38. doi request reprint Is age a risk factor for Candida glabrata colonisation?
    Anurag N Malani
    Division of Infectious Diseases, Veterans Affairs Ann Arbor Healthcare System and University of Michigan Health System, Ann Arbor, MI 48105, USA
    Mycoses 54:531-7. 2011
    ..Dentures are strongly associated with colonisation with any yeast and with C. glabrata. Further study is needed to evaluate the relationship of these findings to increasing C. glabrata infections in older adults...
  39. ncbi request reprint Candida albicans sternal wound infections: a chronic and recurrent complication of median sternotomy
    Preeti N Malani
    Division of Infectious Diseases, Department of Internal Medicine, Veterans Affairs Ann Arbor Healthcare System, University of Michigan Medical School, Ann Arbor, MI 48105, USA
    Clin Infect Dis 35:1316-20. 2002
    ..Of 10 patients for whom follow-up data were available, 7 were cured after initial therapy (median duration of treatment, 6 months), and 3 experienced a relapse and required a second course of fluconazole...
  40. ncbi request reprint Experience with community-based amphotericin B infusion therapy
    Preeti N Malani
    Division of Infectious Diseases, Department of Internal Medicine, University of Michigan Health System, Ann Arbor, 48109, USA
    Pharmacotherapy 25:690-7. 2005
    ..A second objective was to validate the effectiveness of a monitoring system, based on guidelines from the Infectious Diseases Society of America (IDSA)...
  41. pmc Mupirocin-based decolonization of Staphylococcus aureus carriers in residents of 2 long-term care facilities: a randomized, double-blind, placebo-controlled trial
    Lona Mody
    Division of Geriatric Medicine, Department of Internal Medicine, Veterans Affairs Ann Arbor Healthcare System, Ann Arbor, Michigan 48105, USA
    Clin Infect Dis 37:1467-74. 2003
    ..Thirteen (86%) of 14 residents who became recolonized had the same pretherapy strain; no strain recovered during relapse was resistant to mupirocin. A trend toward reduction in infections was seen with mupirocin treatment...
  42. doi request reprint Pulmonary fungal infections
    Jeannina A Smith
    Division of Infectious Diseases, University of Michigan Medical School, Ann Arbor, USA
    Respirology 17:913-26. 2012
    ..The emergence of azole resistance among Aspergillus species is especially worrisome and is likely related to increased azole use for treatment of patients, but also to agricultural use of azoles as fungicides in certain countries...
  43. doi request reprint Invasive fungal infections among organ transplant recipients: results of the Transplant-Associated Infection Surveillance Network (TRANSNET)
    Peter G Pappas
    Division of Infectious Diseases, Department of Medicine, University of Alabama at Birmingham Medical Center, Birmingham, Alabama 35294 0006, USA
    Clin Infect Dis 50:1101-11. 2010
    ..Invasive fungal infections (IFIs) are a major cause of morbidity and mortality among organ transplant recipients. Multicenter prospective surveillance data to determine disease burden and secular trends are lacking...
  44. ncbi request reprint Candida glabrata fungemia: experience in a tertiary care center
    Anurag Malani
    Division of Infectious Diseases, Department of Internal Medicine, University of Michigan Medical School, Veterans Affairs Ann Arbor Healthcare System, Ann Arbor, MI 48105, USA
    Clin Infect Dis 41:975-81. 2005
    ..We reviewed demographic data, risk factors, treatment, and outcomes associated with C. glabrata fungemia from 1995-2002 and performed susceptibility testing of isolates...
  45. ncbi request reprint Candida urinary tract infections: treatment options
    Anurag N Malani
    Division of Infectious Diseases, Veterans Affairs Ann Arbor Healthcare System, Internal Medicine, University of Michigan Health System, 2215 Fuller Road, Ann Arbor, MI 48105, USA
    Expert Rev Anti Infect Ther 5:277-84. 2007
    ..Rarely, amphotericin B or flucytosine are used. Newer azole agents and echinocandins are not recommended for the treatment of urinary tract infections since they fail to achieve adequate urine concentrations...
  46. doi request reprint Clinical practice guidelines for the management of candidiasis: 2009 update by the Infectious Diseases Society of America
    Peter G Pappas
    Department of Medicine, Division of Infectious Diseases, University of Alabama at Birmingham, Birmingham, Alabama 35294 0006, USA
    Clin Infect Dis 48:503-35. 2009
    ..This new information is incorporated into this revised document...
  47. ncbi request reprint Risk factors for arthralgias or myalgias associated with quinupristin-dalfopristin therapy
    Peggy L Carver
    College of Pharmacy, University of Michigan, Ann Arbor 48109 1065, USA
    Pharmacotherapy 23:159-64. 2003
    ..To evaluate risk factors for the development of arthralgias or myalgias associated with quinupristin-dalfopristin...
  48. pmc Cardiobacterium hominis endocarditis: Two cases and a review of the literature
    A N Malani
    Division of Infectious Diseases, University of Michigan Medical School, Veterans Affairs Ann Arbor Healthcare System, Ann Arbor, 2215 Fuller Road, Ann Arbor, MI 48105, USA
    Eur J Clin Microbiol Infect Dis 25:587-95. 2006
    ..The cure rate among 60 patients reviewed was 93% (56/60). For prosthetic valve endocarditis, the cure rate was 16/17 (94%). Valve replacement was required in 27 (45%) cases...
  49. doi request reprint Treatment of endogenous fungal endophthalmitis: focus on new antifungal agents
    James Riddell
    Department of Internal Medicine, Division of Infectious Diseases, University of Michigan Medical School, Ann Arbor, Michigan, USA
    Clin Infect Dis 52:648-53. 2011
    ..We review the available evidence regarding the most appropriate use of antifungal agents for endogenous fungal endophthalmitis, with the emphasis on treatment of infections due to Candida species...
  50. doi request reprint HIV-infected patients with anal carcinoma who subsequently developed oral squamous cell carcinoma: report of 2 cases
    Krisda Chaiyachati
    University of Michigan Medical School, Ann Arbor, Michigan, USA
    J Int Assoc Physicians AIDS Care (Chic) 7:306-10. 2008
    ..Careful screening for oral cancers may be indicated in HIV-infected patients with HPV-associated anal cancer...
  51. ncbi request reprint Introduction of a waterless alcohol-based hand rub in a long-term-care facility
    Lona Mody
    Division of Geriatric Medicine, Veterans Affairs Ann Arbor Healthcare System, University of Michigan Medical School, Ann Arbor, Michigan 48105, USA
    Infect Control Hosp Epidemiol 24:165-71. 2003
    ..To examine the impact of introduction of an alcohol-based hand rub on hand hygiene knowledge and compliance and hand colonization of healthcare workers (HCWs) in a long-term-care facility (LTCF)...
  52. ncbi request reprint Molecular analysis of vancomycin-resistant Enterococcus faecalis from Michigan hospitals during a 10 year period
    Preeti N Malani
    Department of Internal Medicine, Division of Infectious Disease, Veterans Affairs Healthcare Center and University of Michigan Medical School, Ann Arbor, USA
    J Antimicrob Chemother 49:841-3. 2002
    ..The results of this study suggest inter- and intrahospital dissemination of strains of vancomycin-resistant E. faecalis during a 10 year period in Michigan...
  53. ncbi request reprint Magnitude and duration of elevated gastric pH in patients infected with human immunodeficiency virus after administration of chewable, dispersible, buffered didanosine tablets
    Daryl D DePestel
    Department of Clinical Sciences, College of Pharmacy, University of Michigan, Ann Arbor, Michigan, USA
    Pharmacotherapy 24:1539-45. 2004
    ..0 (TpH>3), and area under the gastric pH versus time curve for pH greater than 3.0 (AUCT>pH 3)...
  54. ncbi request reprint Use of central venous catheter-related bloodstream infection prevention practices by US hospitals
    Sarah L Krein
    Center for Practice Management and Outcomes Research, Veterans Affairs Ann Arbor Healthcare System, Ann Arbor, Michigan, USA
    Mayo Clin Proc 82:672-8. 2007
    ..To examine the extent to which US acute care hospitals have adopted recommended practices to prevent central venous catheter-related bloodstream infections (CR-BSIs)...
  55. ncbi request reprint Phialophora verrucosa infection in an AIDS patient
    J M Duggan
    Department of Internal Medicine, Veterans Affairs Medical Center, University of Michigan Medical School, Ann Arbor 48105, USA
    Mycoses 38:215-8. 1995
    ..The disease failed to respond to ketoconazole, but regression of the lesions was obtained with itraconazole...
  56. ncbi request reprint Disseminated Dactylaria constricta infection in a renal transplant recipient
    P N Malani
    Division of Infectious Diseases, Department of Internal Medicine, Veterans Affairs Healthcare System, University of Michigan Medical School, Ann Arbor, Michigan 48105, USA
    Transpl Infect Dis 3:40-3. 2001
    ..We report the case of a 32-year-old renal transplant recipient who developed disseminated Dactylaria constricta infection. The patient died despite treatment with amphotericin B, itraconazole, and fluconazole...
  57. ncbi request reprint Home intravenous antimicrobial infusion therapy: a viable option in older adults
    Amanda M Cox
    Division of General Medicine, Department of Internal Medicine, Veterans Affairs Ann Arbor Healthcare System, University of Michigan Health System, Ann Arbor, MI, USA
    J Am Geriatr Soc 55:645-50. 2007
    ..To determine whether older adults and younger adults are equally able to administer home intravenous antimicrobial infusion therapy (home IV antimicrobials) without intensive support from home care agencies...
  58. ncbi request reprint Fever of unknown origin. A strategic approach to this diagnostic dilemma
    Kamal Amin
    Infectious Diseases Division, University of Michigan Medical Center, Ann Arbor, MI, USA
    Postgrad Med 114:69-75. 2003
    ..Here, Drs Amin and Kauffman review the major causes of FUO in adults and describe an in-depth approach to laboratory and radiologic tests that help establish a diagnosis...
  59. ncbi request reprint Improving the safety of intravenous admixtures: lessons learned from a Pentostam overdose
    Shannon Just
    Department of Veterans Affairs Ann Arbor Healthcare System, Michigan, USA
    Jt Comm J Qual Patient Saf 32:366-72. 2006
    ..Weaknesses in the multistep process of admixture preparation and administration resulted in a patient with cutaneous leishmaniasis (CL) receiving a 10-fold intravenous (IV) overdose of Pentostam (sodium stibogluconalte), a rarely used drug...
  60. ncbi request reprint Trends in species causing fungaemia in a tertiary care medical centre over 12 years
    P N Malani
    Department of Internal Medicine, Veterans Affairs Healthcare System, University of Michigan Medical School, Ann Arbor 48105, USA
    Mycoses 44:446-9. 2001
    ..glabrata and decreasing isolation of C. albicans were associated with increasing usage of fluconazole, but changes in the proportion of fungaemias due to other species appeared to have no association with fluconazole usage...
  61. ncbi request reprint Need for alternative trial designs and evaluation strategies for therapeutic studies of invasive mycoses
    J H Rex
    Division of Infectious Diseases, Department of Internal Medicine, Center for the Study of Emerging and Reemerging Pathogens, University of Texas Medical School, Houston, TX, USA
    Clin Infect Dis 33:95-106. 2001
    ..Therefore, there is a need for alternative trial designs and evaluation strategies for therapeutic studies of invasive mycoses, and this article summarizes the possible strategies in this area...
  62. ncbi request reprint Effective suppression of vancomycin-resistant Enterococcus species in asymptomatic gastrointestinal carriers by a novel glycolipodepsipeptide, ramoplanin
    M T Wong
    Department of Internal Medicine, Medical College of Virginia, Virginia Commonwealth University, Richmond, Virginia, USA
    Clin Infect Dis 33:1476-82. 2001
    ..By day 21, there were no differences between treatment groups. Adverse events were similar for all treatment groups. Ramoplanin was safe and effective in temporarily suppressing gastrointestinal VRE carriage...
  63. ncbi request reprint Outbreak of sternal surgical site infections due to Pseudomonas aeruginosa traced to a scrub nurse with onychomycosis
    S A McNeil
    Division of Infectious Diseases, Department of Internal Medicine, Veterans Affairs Ann Arbor Healthcare System and University of Michigan Medical School, Ann Arbor, MI 48105, USA
    Clin Infect Dis 33:317-23. 2001
    ..aeruginosa strain. This outbreak of surgical site infections due to P. aeruginosa was caused by wound contamination from the thumbnail of this nurse, despite her appropriate use of latex surgical gloves...
  64. doi request reprint The evolution of resistant Candida species in cancer centers: implications for treatment and prophylaxis
    James Riddell
    Cancer 112:2334-7. 2008
  65. ncbi request reprint Histoplasmosis
    L Joseph Wheat
    MiraVista Diagnostics, 4444 Decatur Boulevard, Suite 300, Indianapolis, IN 46241, USA
    Infect Dis Clin North Am 17:1-19, vii. 2003
    ..This article provides an up-to-date clinical review of histoplasmosis, focusing on recognition, diagnosis, and management...
  66. ncbi request reprint Safety and efficacy of liposomal amphotericin B compared with conventional amphotericin B for induction therapy of histoplasmosis in patients with AIDS
    Philip C Johnson
    Division of General Medicine, University of Texas Houston Medical School, 6431 Fannin, MSB 1 122, Houston, TX 77030, USA
    Ann Intern Med 137:105-9. 2002
    ..In patients with moderate to severe histoplasmosis associated with AIDS, the preferred treatment has been the deoxycholate formulation of amphotericin B. However, serious side effects are associated with use of amphotericin B...
  67. pmc Antifungal susceptibility survey of 2,000 bloodstream Candida isolates in the United States
    Luis Ostrosky-Zeichner
    University of Texas Houston Medical School, Houston, Texas, USA
    Antimicrob Agents Chemother 47:3149-54. 2003
    ....
  68. ncbi request reprint Posaconazole
    Carol A Kauffman
    Nat Rev Drug Discov 6:183-4. 2007
  69. ncbi request reprint A prospective observational study of candidemia: epidemiology, therapy, and influences on mortality in hospitalized adult and pediatric patients
    Peter G Pappas
    University of Alabama at Birmingham, 35294 0006, USA
    Clin Infect Dis 37:634-43. 2003
    ..6 vs. 16.1), which suggests that the former subjects are more often excluded from therapeutic trials...
  70. ncbi request reprint Clinical practice guidelines for the management of patients with histoplasmosis: 2007 update by the Infectious Diseases Society of America
    L Joseph Wheat
    MiraVista Diagnostics MiraBella Technologies, Indianapolis, IN 46241, USA
    Clin Infect Dis 45:807-25. 2007
    ..In addition, the panel added recommendations for management of histoplasmosis in children for those aspects that differ from aspects in adults...
  71. pmc Fungemia caused by Zygoascus hellenicus in an allogeneic stem cell transplant recipient
    Mary E Brandt
    Mycotic Diseases Branch, Division of Bacterial and Mycotic Diseases, Centers for Disease Control and Prevention, 1600 Clifton Rd, Mailstop G 11, Atlanta, GA 30333, USA
    J Clin Microbiol 42:3363-5. 2004
    ..The organism was misidentified by a commercial yeast identification system. This is the first reported case of human infection with this rare ascomycetous yeast...
  72. ncbi request reprint Zygomycosis: reemergence of an old pathogen
    Carol A Kauffman
    Clin Infect Dis 39:588-90. 2004
  73. pmc Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) C
    Ben de Pauw
    Department of Blood Transfusion Service and Transplant Immunology, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands
    Clin Infect Dis 46:1813-21. 2008
    ..Clarity and uniformity in defining these infections are important factors in improving the quality of clinical studies. A standard set of definitions strengthens the consistency and reproducibility of such studies...
  74. ncbi request reprint Clinical problem-solving. Building a diagnosis from the ground up--a 49-year-old man came to the clinic with a 1-week history of suprapubic pain and fever
    Brook Watts
    Louis Stokes Cleveland Veterans Affairs Medical Center and the Department of Medicine, Case Western Reserve University, Cleveland, OH 44106, USA
    N Engl J Med 356:1456-62. 2007
  75. doi request reprint Clinical practice guidelines for the management of blastomycosis: 2008 update by the Infectious Diseases Society of America
    Stanley W Chapman
    University of Mississippi Medical Center, Jackson, USA
    Clin Infect Dis 46:1801-12. 2008
    ..New information, based on publications between 2000 and 2006, is incorporated in this guideline document, and recommendations for treating children with blastomycosis have been noted...